Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Thyroid Eye Disease – What to Expect
source: Kellogg Eye Center / University of Michigan Health
year: N/A
summary/abstract:How does the disease progress?
There are two phases. The active phase, marked by inflammation, usually lasts from six months to two years. The focus during this stage is on medical treatment to relieve the eye symptoms. During the second phase, or the stable phase, inflammation and other symptoms have subsided. The patient may need surgery to correct the more visible effects of the disease.
read moreRelated Content
-
Efficacy of Orbital Radiotherapy in Moderate-to-Severe Active Graves’ Orbitopathy Including Long-Lasting Disease: ...Background: We aimed to explore the eff...
-
Mycophenolate Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-Severe Graves’ Or...Background: European guidelines recomme...
-
Rebecca S. Bahn, MDRebecca S. Bahn is the Professor Emeritu...
-
Efficacy and Safety of Immunosuppressive Agents for Thyroid Eye DiseasePurpose: To present an update on the ef...
-
Tackling Thyroid Eye Disease (TED) – A Caregiver’s Storyhttps://www.youtube.com/watch?v=tlZiW0N7...
-
A Prospective, Randomized Trial of Intravenous Glucocorticoids Therapy With Different Protocols for Patients With Gr...Background: For patients with active mo...
-
Recent Developments in Graves’ OphthalmopathyRecent Developments in Graves' ophthalmo...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.